International Journal of Infectious Diseases · 2012 · 43 citations · 23 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceBacteriologyMedical MicrobiologyAntibiotic ResistanceAntibiotic Resistance GeneticsAntibiotic Resistance MechanismsAntimicrobial Susceptibility TestingBacterial EpidemiologyBacterial InfectionsAntibiotic Resistance ScreeningAntibiotic Sensitivity TestingAntibiotic Susceptibility TestingDrug Resistance Pattern AnalysisEpidemiology Of Bacterial InfectionsInvasive InfectionResistance Mechanisms In StreptococciVancomycin Resistance Genes
OBJECTIVE: To compare the prevalence, phenotypes, and genes responsible for erythromycin resistance among Streptococcus pyogenes isolates from Mexico and the USA. METHODS: Eighty-nine invasive and 378 non-invasive isolates from Mexico, plus 148 invasive, 21 non-invasive, and five unclassified isolates from the USA were studied. Susceptibilities to penicillin, erythromycin, clindamycin, ceftriaxone, and vancomycin were evaluated according to Clinical and Laboratory Standards Institute (CLSI) standards. Phenotypes of erythromycin resistance were identified by triple disk test, and screening for mefA, ermTR, and ermB genes was carried out by PCR. RESULTS: All isolates were susceptible to penicillin, ceftriaxone, and vancomycin. Erythromycin resistance was found in 4.9% of Mexican strains and 5.2% of USA strains. Phenotypes in Mexican strains were 95% M and 5% cMLS; in strains from the USA, phenotypes were 33.3% iMLS, 33.3% iMLS-D, and 33.3% M. Erythromycin resistance genes in strains from Mexico were mefA (95%) and ermB (5%); USA strains harbored ermTR (56%), mefA (33%), and none (11%). In Mexico, all erythromycin-resistant strains were non-invasive, whereas 89% of strains from the USA were invasive. CONCLUSIONS: Erythromycin resistance continues to exist at low levels in both Mexico and the USA, although the genetic mechanisms responsible differ between the two nations. These genetic differences may be related to the invasive character of the S. pyogenes isolated.
23
Principles and Practice of Infectious Diseases.
Annals of Internal Medicine · 1991 · 12.1K citations
Performance standards for antimicrobial susceptibility testing
Mary Jane Ferraro · 2001 · 9.8K citations
Surbhi Malhotra‐Kumar, Christine Lammens, Samuel Coenen et al. · The Lancet · 2007 · 553 citations
Pharmacy, Microbiology, Pharmacology +17
Resistance to Erythromycin in Group A Streptococci
Helena Seppälä, A Nissinen, H Järvinen et al. · New England Journal of Medicine · 1992 · 353 citations · Full text